nodes	percent_of_prediction	percent_of_DWPC	metapath
Zonisamide—AOX1—Methotrexate—urinary bladder cancer	0.0173	0.676	CbGbCtD
Zonisamide—SCN1B—prostate gland—urinary bladder cancer	0.011	0.0409	CbGeAlD
Zonisamide—CA8—prostate gland—urinary bladder cancer	0.0104	0.0384	CbGeAlD
Zonisamide—SCN3B—prostate gland—urinary bladder cancer	0.0102	0.0377	CbGeAlD
Zonisamide—CA13—prostate gland—urinary bladder cancer	0.00888	0.0329	CbGeAlD
Zonisamide—SCN4B—prostate gland—urinary bladder cancer	0.00866	0.0321	CbGeAlD
Zonisamide—CA11—prostate gland—urinary bladder cancer	0.00745	0.0276	CbGeAlD
Zonisamide—SCN4B—seminal vesicle—urinary bladder cancer	0.00732	0.0271	CbGeAlD
Zonisamide—CA11—seminal vesicle—urinary bladder cancer	0.0063	0.0233	CbGeAlD
Zonisamide—SCN1B—female reproductive system—urinary bladder cancer	0.00602	0.0223	CbGeAlD
Zonisamide—SCN4B—urethra—urinary bladder cancer	0.0058	0.0215	CbGeAlD
Zonisamide—CA10—female reproductive system—urinary bladder cancer	0.00577	0.0214	CbGeAlD
Zonisamide—CYP3A4—Thiotepa—urinary bladder cancer	0.0057	0.223	CbGbCtD
Zonisamide—SCN3B—vagina—urinary bladder cancer	0.00503	0.0186	CbGeAlD
Zonisamide—CYP2C19—urine—urinary bladder cancer	0.00503	0.0186	CbGeAlD
Zonisamide—CA11—urethra—urinary bladder cancer	0.00499	0.0185	CbGeAlD
Zonisamide—CA3—prostate gland—urinary bladder cancer	0.00455	0.0168	CbGeAlD
Zonisamide—CA13—vagina—urinary bladder cancer	0.00438	0.0162	CbGeAlD
Zonisamide—SCN4B—vagina—urinary bladder cancer	0.00427	0.0158	CbGeAlD
Zonisamide—CA14—prostate gland—urinary bladder cancer	0.00413	0.0153	CbGeAlD
Zonisamide—CA5A—female reproductive system—urinary bladder cancer	0.00407	0.0151	CbGeAlD
Zonisamide—CA11—female reproductive system—urinary bladder cancer	0.00407	0.0151	CbGeAlD
Zonisamide—SCN9A—prostate gland—urinary bladder cancer	0.00405	0.015	CbGeAlD
Zonisamide—CACNA1H—prostate gland—urinary bladder cancer	0.00379	0.014	CbGeAlD
Zonisamide—CA11—vagina—urinary bladder cancer	0.00368	0.0136	CbGeAlD
Zonisamide—SCN4A—prostate gland—urinary bladder cancer	0.00361	0.0134	CbGeAlD
Zonisamide—SCN1B—lymph node—urinary bladder cancer	0.00352	0.013	CbGeAlD
Zonisamide—CA14—seminal vesicle—urinary bladder cancer	0.00349	0.0129	CbGeAlD
Zonisamide—CA7—renal system—urinary bladder cancer	0.00338	0.0125	CbGeAlD
Zonisamide—CA8—lymph node—urinary bladder cancer	0.00331	0.0123	CbGeAlD
Zonisamide—SCN3B—lymph node—urinary bladder cancer	0.00325	0.012	CbGeAlD
Zonisamide—CACNA1H—seminal vesicle—urinary bladder cancer	0.00321	0.0119	CbGeAlD
Zonisamide—CYP3A4—urine—urinary bladder cancer	0.00297	0.011	CbGeAlD
Zonisamide—CA5B—prostate gland—urinary bladder cancer	0.00289	0.0107	CbGeAlD
Zonisamide—CA13—lymph node—urinary bladder cancer	0.00283	0.0105	CbGeAlD
Zonisamide—SCN3A—prostate gland—urinary bladder cancer	0.00281	0.0104	CbGeAlD
Zonisamide—SCN4B—lymph node—urinary bladder cancer	0.00276	0.0102	CbGeAlD
Zonisamide—CACNA1I—lymph node—urinary bladder cancer	0.0027	0.01	CbGeAlD
Zonisamide—AOX1—prostate gland—urinary bladder cancer	0.00269	0.00995	CbGeAlD
Zonisamide—CACNA1H—smooth muscle tissue—urinary bladder cancer	0.00268	0.00994	CbGeAlD
Zonisamide—SCN4A—renal system—urinary bladder cancer	0.00246	0.00911	CbGeAlD
Zonisamide—CA11—lymph node—urinary bladder cancer	0.00238	0.00881	CbGeAlD
Zonisamide—CA9—female reproductive system—urinary bladder cancer	0.00238	0.0088	CbGeAlD
Zonisamide—AOX1—seminal vesicle—urinary bladder cancer	0.00227	0.00842	CbGeAlD
Zonisamide—CA3—vagina—urinary bladder cancer	0.00224	0.00831	CbGeAlD
Zonisamide—CA12—renal system—urinary bladder cancer	0.00219	0.00813	CbGeAlD
Zonisamide—MAOB—prostate gland—urinary bladder cancer	0.00207	0.00767	CbGeAlD
Zonisamide—CACNA1H—female reproductive system—urinary bladder cancer	0.00207	0.00766	CbGeAlD
Zonisamide—CA4—prostate gland—urinary bladder cancer	0.00199	0.00739	CbGeAlD
Zonisamide—CA5B—urethra—urinary bladder cancer	0.00193	0.00716	CbGeAlD
Zonisamide—SCN3A—renal system—urinary bladder cancer	0.00191	0.00709	CbGeAlD
Zonisamide—AOX1—renal system—urinary bladder cancer	0.00183	0.00678	CbGeAlD
Zonisamide—AOX1—urethra—urinary bladder cancer	0.0018	0.00666	CbGeAlD
Zonisamide—MAOA—prostate gland—urinary bladder cancer	0.00177	0.00654	CbGeAlD
Zonisamide—CA12—female reproductive system—urinary bladder cancer	0.00176	0.00651	CbGeAlD
Zonisamide—MAOB—seminal vesicle—urinary bladder cancer	0.00175	0.00649	CbGeAlD
Zonisamide—CA1—renal system—urinary bladder cancer	0.00174	0.00644	CbGeAlD
Zonisamide—CA4—seminal vesicle—urinary bladder cancer	0.00169	0.00625	CbGeAlD
Zonisamide—CA2—prostate gland—urinary bladder cancer	0.00165	0.00612	CbGeAlD
Zonisamide—SCN2A—vagina—urinary bladder cancer	0.00158	0.00584	CbGeAlD
Zonisamide—CA5B—female reproductive system—urinary bladder cancer	0.00158	0.00584	CbGeAlD
Zonisamide—CYP3A4—Etoposide—urinary bladder cancer	0.00155	0.0603	CbGbCtD
Zonisamide—SCN3A—female reproductive system—urinary bladder cancer	0.00153	0.00568	CbGeAlD
Zonisamide—MAOA—seminal vesicle—urinary bladder cancer	0.00149	0.00553	CbGeAlD
Zonisamide—AOX1—female reproductive system—urinary bladder cancer	0.00147	0.00543	CbGeAlD
Zonisamide—CA3—lymph node—urinary bladder cancer	0.00145	0.00538	CbGeAlD
Zonisamide—CA5B—vagina—urinary bladder cancer	0.00143	0.00528	CbGeAlD
Zonisamide—MAOB—renal system—urinary bladder cancer	0.00141	0.00523	CbGeAlD
Zonisamide—CA2—seminal vesicle—urinary bladder cancer	0.0014	0.00518	CbGeAlD
Zonisamide—CA1—female reproductive system—urinary bladder cancer	0.00139	0.00516	CbGeAlD
Zonisamide—MAOB—urethra—urinary bladder cancer	0.00139	0.00513	CbGeAlD
Zonisamide—SCN3A—vagina—urinary bladder cancer	0.00139	0.00513	CbGeAlD
Zonisamide—SCN5A—vagina—urinary bladder cancer	0.00138	0.00512	CbGeAlD
Zonisamide—CA4—renal system—urinary bladder cancer	0.00136	0.00503	CbGeAlD
Zonisamide—CA4—urethra—urinary bladder cancer	0.00133	0.00494	CbGeAlD
Zonisamide—AOX1—vagina—urinary bladder cancer	0.00133	0.00491	CbGeAlD
Zonisamide—SCN9A—lymph node—urinary bladder cancer	0.00129	0.00478	CbGeAlD
Zonisamide—CA2—epithelium—urinary bladder cancer	0.00121	0.0045	CbGeAlD
Zonisamide—CACNA1H—lymph node—urinary bladder cancer	0.00121	0.00448	CbGeAlD
Zonisamide—MAOA—renal system—urinary bladder cancer	0.0012	0.00446	CbGeAlD
Zonisamide—MAOA—urethra—urinary bladder cancer	0.00118	0.00438	CbGeAlD
Zonisamide—CA2—smooth muscle tissue—urinary bladder cancer	0.00117	0.00434	CbGeAlD
Zonisamide—MAOB—female reproductive system—urinary bladder cancer	0.00113	0.00419	CbGeAlD
Zonisamide—CA2—renal system—urinary bladder cancer	0.00113	0.00417	CbGeAlD
Zonisamide—CA4—female reproductive system—urinary bladder cancer	0.00109	0.00403	CbGeAlD
Zonisamide—CYP3A4—Doxorubicin—urinary bladder cancer	0.00105	0.0412	CbGbCtD
Zonisamide—MAOB—vagina—urinary bladder cancer	0.00102	0.00379	CbGeAlD
Zonisamide—MAOA—female reproductive system—urinary bladder cancer	0.000964	0.00357	CbGeAlD
Zonisamide—CA5B—lymph node—urinary bladder cancer	0.000922	0.00342	CbGeAlD
Zonisamide—CA2—female reproductive system—urinary bladder cancer	0.000902	0.00334	CbGeAlD
Zonisamide—SCN3A—lymph node—urinary bladder cancer	0.000896	0.00332	CbGeAlD
Zonisamide—CYP2C19—vagina—urinary bladder cancer	0.000891	0.0033	CbGeAlD
Zonisamide—MAOA—vagina—urinary bladder cancer	0.000872	0.00323	CbGeAlD
Zonisamide—AOX1—lymph node—urinary bladder cancer	0.000858	0.00318	CbGeAlD
Zonisamide—CA2—vagina—urinary bladder cancer	0.000816	0.00302	CbGeAlD
Zonisamide—CA1—lymph node—urinary bladder cancer	0.000815	0.00302	CbGeAlD
Zonisamide—CYP3A4—renal system—urinary bladder cancer	0.000727	0.00269	CbGeAlD
Zonisamide—MAOB—lymph node—urinary bladder cancer	0.000661	0.00245	CbGeAlD
Zonisamide—CA4—lymph node—urinary bladder cancer	0.000637	0.00236	CbGeAlD
Zonisamide—CYP3A4—female reproductive system—urinary bladder cancer	0.000582	0.00216	CbGeAlD
Zonisamide—MAOA—lymph node—urinary bladder cancer	0.000564	0.00209	CbGeAlD
Zonisamide—CA2—lymph node—urinary bladder cancer	0.000528	0.00196	CbGeAlD
Zonisamide—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000248	0.000564	CcSEcCtD
Zonisamide—Pneumonia—Doxorubicin—urinary bladder cancer	0.000247	0.000563	CcSEcCtD
Zonisamide—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000247	0.000563	CcSEcCtD
Zonisamide—Pruritus—Fluorouracil—urinary bladder cancer	0.000246	0.00056	CcSEcCtD
Zonisamide—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000244	0.000555	CcSEcCtD
Zonisamide—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000243	0.000553	CcSEcCtD
Zonisamide—Bradycardia—Epirubicin—urinary bladder cancer	0.000243	0.000553	CcSEcCtD
Zonisamide—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000242	0.000551	CcSEcCtD
Zonisamide—Renal failure—Doxorubicin—urinary bladder cancer	0.000242	0.00055	CcSEcCtD
Zonisamide—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000241	0.000548	CcSEcCtD
Zonisamide—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000241	0.000548	CcSEcCtD
Zonisamide—Urticaria—Etoposide—urinary bladder cancer	0.00024	0.000547	CcSEcCtD
Zonisamide—Stomatitis—Doxorubicin—urinary bladder cancer	0.00024	0.000545	CcSEcCtD
Zonisamide—Rhinitis—Epirubicin—urinary bladder cancer	0.000239	0.000544	CcSEcCtD
Zonisamide—Body temperature increased—Etoposide—urinary bladder cancer	0.000239	0.000544	CcSEcCtD
Zonisamide—Abdominal pain—Etoposide—urinary bladder cancer	0.000239	0.000544	CcSEcCtD
Zonisamide—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000239	0.000544	CcSEcCtD
Zonisamide—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000239	0.000544	CcSEcCtD
Zonisamide—Eye disorder—Methotrexate—urinary bladder cancer	0.000238	0.000542	CcSEcCtD
Zonisamide—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000238	0.000542	CcSEcCtD
Zonisamide—Tinnitus—Methotrexate—urinary bladder cancer	0.000238	0.000541	CcSEcCtD
Zonisamide—Asthenia—Cisplatin—urinary bladder cancer	0.000237	0.000539	CcSEcCtD
Zonisamide—Pharyngitis—Epirubicin—urinary bladder cancer	0.000237	0.000539	CcSEcCtD
Zonisamide—Sweating—Doxorubicin—urinary bladder cancer	0.000236	0.000536	CcSEcCtD
Zonisamide—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000236	0.000536	CcSEcCtD
Zonisamide—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000235	0.000535	CcSEcCtD
Zonisamide—Haematuria—Doxorubicin—urinary bladder cancer	0.000235	0.000533	CcSEcCtD
Zonisamide—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000235	0.000533	CcSEcCtD
Zonisamide—Urethral disorder—Epirubicin—urinary bladder cancer	0.000234	0.000532	CcSEcCtD
Zonisamide—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000233	0.000529	CcSEcCtD
Zonisamide—Immune system disorder—Methotrexate—urinary bladder cancer	0.00023	0.000524	CcSEcCtD
Zonisamide—Dizziness—Fluorouracil—urinary bladder cancer	0.00023	0.000524	CcSEcCtD
Zonisamide—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.00023	0.000523	CcSEcCtD
Zonisamide—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.00023	0.000522	CcSEcCtD
Zonisamide—Diarrhoea—Cisplatin—urinary bladder cancer	0.000226	0.000514	CcSEcCtD
Zonisamide—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000226	0.000513	CcSEcCtD
Zonisamide—Alopecia—Methotrexate—urinary bladder cancer	0.000225	0.000513	CcSEcCtD
Zonisamide—Vomiting—Gemcitabine—urinary bladder cancer	0.000225	0.000512	CcSEcCtD
Zonisamide—Bradycardia—Doxorubicin—urinary bladder cancer	0.000225	0.000511	CcSEcCtD
Zonisamide—Mental disorder—Methotrexate—urinary bladder cancer	0.000223	0.000508	CcSEcCtD
Zonisamide—Rash—Gemcitabine—urinary bladder cancer	0.000223	0.000508	CcSEcCtD
Zonisamide—Dermatitis—Gemcitabine—urinary bladder cancer	0.000223	0.000507	CcSEcCtD
Zonisamide—Eye disorder—Epirubicin—urinary bladder cancer	0.000223	0.000507	CcSEcCtD
Zonisamide—Hypersensitivity—Etoposide—urinary bladder cancer	0.000223	0.000507	CcSEcCtD
Zonisamide—Tinnitus—Epirubicin—urinary bladder cancer	0.000223	0.000506	CcSEcCtD
Zonisamide—Malnutrition—Methotrexate—urinary bladder cancer	0.000222	0.000505	CcSEcCtD
Zonisamide—Headache—Gemcitabine—urinary bladder cancer	0.000222	0.000505	CcSEcCtD
Zonisamide—Vomiting—Fluorouracil—urinary bladder cancer	0.000221	0.000504	CcSEcCtD
Zonisamide—Rhinitis—Doxorubicin—urinary bladder cancer	0.000221	0.000503	CcSEcCtD
Zonisamide—Rash—Fluorouracil—urinary bladder cancer	0.00022	0.000499	CcSEcCtD
Zonisamide—Dermatitis—Fluorouracil—urinary bladder cancer	0.000219	0.000499	CcSEcCtD
Zonisamide—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000219	0.000498	CcSEcCtD
Zonisamide—Headache—Fluorouracil—urinary bladder cancer	0.000218	0.000496	CcSEcCtD
Zonisamide—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000218	0.000496	CcSEcCtD
Zonisamide—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000218	0.000495	CcSEcCtD
Zonisamide—Dysgeusia—Methotrexate—urinary bladder cancer	0.000217	0.000494	CcSEcCtD
Zonisamide—Asthenia—Etoposide—urinary bladder cancer	0.000217	0.000494	CcSEcCtD
Zonisamide—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000217	0.000494	CcSEcCtD
Zonisamide—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000217	0.000492	CcSEcCtD
Zonisamide—Immune system disorder—Epirubicin—urinary bladder cancer	0.000216	0.00049	CcSEcCtD
Zonisamide—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000215	0.000489	CcSEcCtD
Zonisamide—Pruritus—Etoposide—urinary bladder cancer	0.000214	0.000487	CcSEcCtD
Zonisamide—Alopecia—Epirubicin—urinary bladder cancer	0.000211	0.00048	CcSEcCtD
Zonisamide—Nausea—Gemcitabine—urinary bladder cancer	0.00021	0.000479	CcSEcCtD
Zonisamide—Vomiting—Cisplatin—urinary bladder cancer	0.00021	0.000477	CcSEcCtD
Zonisamide—Mental disorder—Epirubicin—urinary bladder cancer	0.000209	0.000476	CcSEcCtD
Zonisamide—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000209	0.000475	CcSEcCtD
Zonisamide—Rash—Cisplatin—urinary bladder cancer	0.000208	0.000473	CcSEcCtD
Zonisamide—Dermatitis—Cisplatin—urinary bladder cancer	0.000208	0.000473	CcSEcCtD
Zonisamide—Malnutrition—Epirubicin—urinary bladder cancer	0.000208	0.000472	CcSEcCtD
Zonisamide—Diarrhoea—Etoposide—urinary bladder cancer	0.000207	0.000471	CcSEcCtD
Zonisamide—Nausea—Fluorouracil—urinary bladder cancer	0.000207	0.000471	CcSEcCtD
Zonisamide—Eye disorder—Doxorubicin—urinary bladder cancer	0.000206	0.000469	CcSEcCtD
Zonisamide—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000206	0.000468	CcSEcCtD
Zonisamide—Tinnitus—Doxorubicin—urinary bladder cancer	0.000206	0.000468	CcSEcCtD
Zonisamide—Anaemia—Methotrexate—urinary bladder cancer	0.000205	0.000467	CcSEcCtD
Zonisamide—Flatulence—Epirubicin—urinary bladder cancer	0.000205	0.000466	CcSEcCtD
Zonisamide—Tension—Epirubicin—urinary bladder cancer	0.000204	0.000464	CcSEcCtD
Zonisamide—Dysgeusia—Epirubicin—urinary bladder cancer	0.000203	0.000463	CcSEcCtD
Zonisamide—Nervousness—Epirubicin—urinary bladder cancer	0.000202	0.000459	CcSEcCtD
Zonisamide—Malaise—Methotrexate—urinary bladder cancer	0.0002	0.000455	CcSEcCtD
Zonisamide—Dizziness—Etoposide—urinary bladder cancer	0.0002	0.000455	CcSEcCtD
Zonisamide—Muscle spasms—Epirubicin—urinary bladder cancer	0.0002	0.000454	CcSEcCtD
Zonisamide—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000199	0.000454	CcSEcCtD
Zonisamide—Vertigo—Methotrexate—urinary bladder cancer	0.000199	0.000454	CcSEcCtD
Zonisamide—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000199	0.000453	CcSEcCtD
Zonisamide—Leukopenia—Methotrexate—urinary bladder cancer	0.000199	0.000452	CcSEcCtD
Zonisamide—Nausea—Cisplatin—urinary bladder cancer	0.000196	0.000446	CcSEcCtD
Zonisamide—Alopecia—Doxorubicin—urinary bladder cancer	0.000195	0.000444	CcSEcCtD
Zonisamide—Cough—Methotrexate—urinary bladder cancer	0.000194	0.000441	CcSEcCtD
Zonisamide—Mental disorder—Doxorubicin—urinary bladder cancer	0.000193	0.00044	CcSEcCtD
Zonisamide—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000193	0.000438	CcSEcCtD
Zonisamide—Convulsion—Methotrexate—urinary bladder cancer	0.000192	0.000437	CcSEcCtD
Zonisamide—Vomiting—Etoposide—urinary bladder cancer	0.000192	0.000437	CcSEcCtD
Zonisamide—Malnutrition—Doxorubicin—urinary bladder cancer	0.000192	0.000437	CcSEcCtD
Zonisamide—Anaemia—Epirubicin—urinary bladder cancer	0.000192	0.000437	CcSEcCtD
Zonisamide—Agitation—Epirubicin—urinary bladder cancer	0.000191	0.000434	CcSEcCtD
Zonisamide—Rash—Etoposide—urinary bladder cancer	0.000191	0.000434	CcSEcCtD
Zonisamide—Dermatitis—Etoposide—urinary bladder cancer	0.000191	0.000433	CcSEcCtD
Zonisamide—Headache—Etoposide—urinary bladder cancer	0.00019	0.000431	CcSEcCtD
Zonisamide—Flatulence—Doxorubicin—urinary bladder cancer	0.000189	0.000431	CcSEcCtD
Zonisamide—Myalgia—Methotrexate—urinary bladder cancer	0.000189	0.00043	CcSEcCtD
Zonisamide—Chest pain—Methotrexate—urinary bladder cancer	0.000189	0.00043	CcSEcCtD
Zonisamide—Arthralgia—Methotrexate—urinary bladder cancer	0.000189	0.00043	CcSEcCtD
Zonisamide—Tension—Doxorubicin—urinary bladder cancer	0.000189	0.000429	CcSEcCtD
Zonisamide—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000188	0.000428	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000188	0.000427	CcSEcCtD
Zonisamide—Malaise—Epirubicin—urinary bladder cancer	0.000187	0.000426	CcSEcCtD
Zonisamide—Discomfort—Methotrexate—urinary bladder cancer	0.000187	0.000425	CcSEcCtD
Zonisamide—Nervousness—Doxorubicin—urinary bladder cancer	0.000187	0.000425	CcSEcCtD
Zonisamide—Vertigo—Epirubicin—urinary bladder cancer	0.000187	0.000425	CcSEcCtD
Zonisamide—Syncope—Epirubicin—urinary bladder cancer	0.000186	0.000424	CcSEcCtD
Zonisamide—Leukopenia—Epirubicin—urinary bladder cancer	0.000186	0.000423	CcSEcCtD
Zonisamide—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000185	0.00042	CcSEcCtD
Zonisamide—Palpitations—Epirubicin—urinary bladder cancer	0.000184	0.000418	CcSEcCtD
Zonisamide—Confusional state—Methotrexate—urinary bladder cancer	0.000183	0.000415	CcSEcCtD
Zonisamide—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000183	0.000415	CcSEcCtD
Zonisamide—Cough—Epirubicin—urinary bladder cancer	0.000181	0.000412	CcSEcCtD
Zonisamide—Convulsion—Epirubicin—urinary bladder cancer	0.00018	0.000409	CcSEcCtD
Zonisamide—Infection—Methotrexate—urinary bladder cancer	0.00018	0.000409	CcSEcCtD
Zonisamide—Nausea—Etoposide—urinary bladder cancer	0.00018	0.000409	CcSEcCtD
Zonisamide—Hypertension—Epirubicin—urinary bladder cancer	0.000179	0.000408	CcSEcCtD
Zonisamide—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000178	0.000406	CcSEcCtD
Zonisamide—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000178	0.000404	CcSEcCtD
Zonisamide—Anaemia—Doxorubicin—urinary bladder cancer	0.000178	0.000404	CcSEcCtD
Zonisamide—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000177	0.000403	CcSEcCtD
Zonisamide—Myalgia—Epirubicin—urinary bladder cancer	0.000177	0.000402	CcSEcCtD
Zonisamide—Arthralgia—Epirubicin—urinary bladder cancer	0.000177	0.000402	CcSEcCtD
Zonisamide—Chest pain—Epirubicin—urinary bladder cancer	0.000177	0.000402	CcSEcCtD
Zonisamide—Agitation—Doxorubicin—urinary bladder cancer	0.000177	0.000402	CcSEcCtD
Zonisamide—Anxiety—Epirubicin—urinary bladder cancer	0.000176	0.000401	CcSEcCtD
Zonisamide—Skin disorder—Methotrexate—urinary bladder cancer	0.000176	0.0004	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000176	0.000399	CcSEcCtD
Zonisamide—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000175	0.000398	CcSEcCtD
Zonisamide—Discomfort—Epirubicin—urinary bladder cancer	0.000175	0.000397	CcSEcCtD
Zonisamide—Malaise—Doxorubicin—urinary bladder cancer	0.000173	0.000394	CcSEcCtD
Zonisamide—Dry mouth—Epirubicin—urinary bladder cancer	0.000173	0.000393	CcSEcCtD
Zonisamide—Vertigo—Doxorubicin—urinary bladder cancer	0.000173	0.000393	CcSEcCtD
Zonisamide—Anorexia—Methotrexate—urinary bladder cancer	0.000173	0.000393	CcSEcCtD
Zonisamide—Syncope—Doxorubicin—urinary bladder cancer	0.000172	0.000392	CcSEcCtD
Zonisamide—Leukopenia—Doxorubicin—urinary bladder cancer	0.000172	0.000391	CcSEcCtD
Zonisamide—Confusional state—Epirubicin—urinary bladder cancer	0.000171	0.000389	CcSEcCtD
Zonisamide—Palpitations—Doxorubicin—urinary bladder cancer	0.00017	0.000386	CcSEcCtD
Zonisamide—Oedema—Epirubicin—urinary bladder cancer	0.00017	0.000386	CcSEcCtD
Zonisamide—Hypotension—Methotrexate—urinary bladder cancer	0.000169	0.000385	CcSEcCtD
Zonisamide—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000169	0.000384	CcSEcCtD
Zonisamide—Infection—Epirubicin—urinary bladder cancer	0.000168	0.000383	CcSEcCtD
Zonisamide—Cough—Doxorubicin—urinary bladder cancer	0.000168	0.000382	CcSEcCtD
Zonisamide—Shock—Epirubicin—urinary bladder cancer	0.000167	0.000379	CcSEcCtD
Zonisamide—Convulsion—Doxorubicin—urinary bladder cancer	0.000167	0.000379	CcSEcCtD
Zonisamide—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000166	0.000378	CcSEcCtD
Zonisamide—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000166	0.000378	CcSEcCtD
Zonisamide—Hypertension—Doxorubicin—urinary bladder cancer	0.000166	0.000377	CcSEcCtD
Zonisamide—Tachycardia—Epirubicin—urinary bladder cancer	0.000166	0.000376	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000165	0.000375	CcSEcCtD
Zonisamide—Skin disorder—Epirubicin—urinary bladder cancer	0.000165	0.000375	CcSEcCtD
Zonisamide—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000164	0.000373	CcSEcCtD
Zonisamide—Insomnia—Methotrexate—urinary bladder cancer	0.000164	0.000373	CcSEcCtD
Zonisamide—Chest pain—Doxorubicin—urinary bladder cancer	0.000164	0.000372	CcSEcCtD
Zonisamide—Arthralgia—Doxorubicin—urinary bladder cancer	0.000164	0.000372	CcSEcCtD
Zonisamide—Myalgia—Doxorubicin—urinary bladder cancer	0.000164	0.000372	CcSEcCtD
Zonisamide—Anxiety—Doxorubicin—urinary bladder cancer	0.000163	0.000371	CcSEcCtD
Zonisamide—Paraesthesia—Methotrexate—urinary bladder cancer	0.000163	0.00037	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000163	0.00037	CcSEcCtD
Zonisamide—Discomfort—Doxorubicin—urinary bladder cancer	0.000162	0.000368	CcSEcCtD
Zonisamide—Anorexia—Epirubicin—urinary bladder cancer	0.000162	0.000368	CcSEcCtD
Zonisamide—Dyspnoea—Methotrexate—urinary bladder cancer	0.000162	0.000367	CcSEcCtD
Zonisamide—Somnolence—Methotrexate—urinary bladder cancer	0.000161	0.000366	CcSEcCtD
Zonisamide—Dry mouth—Doxorubicin—urinary bladder cancer	0.00016	0.000364	CcSEcCtD
Zonisamide—Dyspepsia—Methotrexate—urinary bladder cancer	0.00016	0.000363	CcSEcCtD
Zonisamide—Hypotension—Epirubicin—urinary bladder cancer	0.000158	0.00036	CcSEcCtD
Zonisamide—Confusional state—Doxorubicin—urinary bladder cancer	0.000158	0.00036	CcSEcCtD
Zonisamide—Decreased appetite—Methotrexate—urinary bladder cancer	0.000158	0.000358	CcSEcCtD
Zonisamide—Oedema—Doxorubicin—urinary bladder cancer	0.000157	0.000357	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000156	0.000356	CcSEcCtD
Zonisamide—Fatigue—Methotrexate—urinary bladder cancer	0.000156	0.000355	CcSEcCtD
Zonisamide—Infection—Doxorubicin—urinary bladder cancer	0.000156	0.000354	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000155	0.000351	CcSEcCtD
Zonisamide—Shock—Doxorubicin—urinary bladder cancer	0.000154	0.000351	CcSEcCtD
Zonisamide—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000154	0.00035	CcSEcCtD
Zonisamide—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000154	0.000349	CcSEcCtD
Zonisamide—Insomnia—Epirubicin—urinary bladder cancer	0.000153	0.000349	CcSEcCtD
Zonisamide—Tachycardia—Doxorubicin—urinary bladder cancer	0.000153	0.000348	CcSEcCtD
Zonisamide—Skin disorder—Doxorubicin—urinary bladder cancer	0.000152	0.000347	CcSEcCtD
Zonisamide—Paraesthesia—Epirubicin—urinary bladder cancer	0.000152	0.000346	CcSEcCtD
Zonisamide—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000152	0.000345	CcSEcCtD
Zonisamide—Dyspnoea—Epirubicin—urinary bladder cancer	0.000151	0.000344	CcSEcCtD
Zonisamide—Somnolence—Epirubicin—urinary bladder cancer	0.000151	0.000343	CcSEcCtD
Zonisamide—Anorexia—Doxorubicin—urinary bladder cancer	0.00015	0.00034	CcSEcCtD
Zonisamide—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000149	0.00034	CcSEcCtD
Zonisamide—Dyspepsia—Epirubicin—urinary bladder cancer	0.000149	0.000339	CcSEcCtD
Zonisamide—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000148	0.000337	CcSEcCtD
Zonisamide—Decreased appetite—Epirubicin—urinary bladder cancer	0.000147	0.000335	CcSEcCtD
Zonisamide—Hypotension—Doxorubicin—urinary bladder cancer	0.000147	0.000333	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000146	0.000333	CcSEcCtD
Zonisamide—Fatigue—Epirubicin—urinary bladder cancer	0.000146	0.000332	CcSEcCtD
Zonisamide—Constipation—Epirubicin—urinary bladder cancer	0.000145	0.00033	CcSEcCtD
Zonisamide—Urticaria—Methotrexate—urinary bladder cancer	0.000144	0.000327	CcSEcCtD
Zonisamide—Body temperature increased—Methotrexate—urinary bladder cancer	0.000143	0.000326	CcSEcCtD
Zonisamide—Abdominal pain—Methotrexate—urinary bladder cancer	0.000143	0.000326	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000143	0.000325	CcSEcCtD
Zonisamide—Insomnia—Doxorubicin—urinary bladder cancer	0.000142	0.000323	CcSEcCtD
Zonisamide—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000141	0.00032	CcSEcCtD
Zonisamide—Dyspnoea—Doxorubicin—urinary bladder cancer	0.00014	0.000318	CcSEcCtD
Zonisamide—Feeling abnormal—Epirubicin—urinary bladder cancer	0.00014	0.000318	CcSEcCtD
Zonisamide—Somnolence—Doxorubicin—urinary bladder cancer	0.000139	0.000317	CcSEcCtD
Zonisamide—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000139	0.000315	CcSEcCtD
Zonisamide—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000138	0.000314	CcSEcCtD
Zonisamide—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000136	0.00031	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000135	0.000308	CcSEcCtD
Zonisamide—Fatigue—Doxorubicin—urinary bladder cancer	0.000135	0.000308	CcSEcCtD
Zonisamide—Urticaria—Epirubicin—urinary bladder cancer	0.000135	0.000306	CcSEcCtD
Zonisamide—Constipation—Doxorubicin—urinary bladder cancer	0.000134	0.000305	CcSEcCtD
Zonisamide—Abdominal pain—Epirubicin—urinary bladder cancer	0.000134	0.000305	CcSEcCtD
Zonisamide—Body temperature increased—Epirubicin—urinary bladder cancer	0.000134	0.000305	CcSEcCtD
Zonisamide—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000134	0.000304	CcSEcCtD
Zonisamide—Asthenia—Methotrexate—urinary bladder cancer	0.00013	0.000296	CcSEcCtD
Zonisamide—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000129	0.000294	CcSEcCtD
Zonisamide—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000128	0.000292	CcSEcCtD
Zonisamide—Pruritus—Methotrexate—urinary bladder cancer	0.000128	0.000292	CcSEcCtD
Zonisamide—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000125	0.000284	CcSEcCtD
Zonisamide—Urticaria—Doxorubicin—urinary bladder cancer	0.000125	0.000283	CcSEcCtD
Zonisamide—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000124	0.000282	CcSEcCtD
Zonisamide—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000124	0.000282	CcSEcCtD
Zonisamide—Diarrhoea—Methotrexate—urinary bladder cancer	0.000124	0.000282	CcSEcCtD
Zonisamide—Asthenia—Epirubicin—urinary bladder cancer	0.000122	0.000277	CcSEcCtD
Zonisamide—Pruritus—Epirubicin—urinary bladder cancer	0.00012	0.000273	CcSEcCtD
Zonisamide—Dizziness—Methotrexate—urinary bladder cancer	0.00012	0.000272	CcSEcCtD
Zonisamide—Diarrhoea—Epirubicin—urinary bladder cancer	0.000116	0.000264	CcSEcCtD
Zonisamide—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000116	0.000263	CcSEcCtD
Zonisamide—Vomiting—Methotrexate—urinary bladder cancer	0.000115	0.000262	CcSEcCtD
Zonisamide—Rash—Methotrexate—urinary bladder cancer	0.000114	0.00026	CcSEcCtD
Zonisamide—Dermatitis—Methotrexate—urinary bladder cancer	0.000114	0.00026	CcSEcCtD
Zonisamide—Headache—Methotrexate—urinary bladder cancer	0.000114	0.000258	CcSEcCtD
Zonisamide—Asthenia—Doxorubicin—urinary bladder cancer	0.000113	0.000256	CcSEcCtD
Zonisamide—Dizziness—Epirubicin—urinary bladder cancer	0.000112	0.000255	CcSEcCtD
Zonisamide—Pruritus—Doxorubicin—urinary bladder cancer	0.000111	0.000252	CcSEcCtD
Zonisamide—Vomiting—Epirubicin—urinary bladder cancer	0.000108	0.000245	CcSEcCtD
Zonisamide—Nausea—Methotrexate—urinary bladder cancer	0.000108	0.000245	CcSEcCtD
Zonisamide—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000107	0.000244	CcSEcCtD
Zonisamide—Rash—Epirubicin—urinary bladder cancer	0.000107	0.000243	CcSEcCtD
Zonisamide—Dermatitis—Epirubicin—urinary bladder cancer	0.000107	0.000243	CcSEcCtD
Zonisamide—Headache—Epirubicin—urinary bladder cancer	0.000106	0.000242	CcSEcCtD
Zonisamide—Dizziness—Doxorubicin—urinary bladder cancer	0.000104	0.000236	CcSEcCtD
Zonisamide—Nausea—Epirubicin—urinary bladder cancer	0.000101	0.000229	CcSEcCtD
Zonisamide—Vomiting—Doxorubicin—urinary bladder cancer	9.98e-05	0.000227	CcSEcCtD
Zonisamide—Rash—Doxorubicin—urinary bladder cancer	9.89e-05	0.000225	CcSEcCtD
Zonisamide—Dermatitis—Doxorubicin—urinary bladder cancer	9.88e-05	0.000225	CcSEcCtD
Zonisamide—Headache—Doxorubicin—urinary bladder cancer	9.83e-05	0.000224	CcSEcCtD
Zonisamide—Nausea—Doxorubicin—urinary bladder cancer	9.32e-05	0.000212	CcSEcCtD
Zonisamide—CA12—Metabolism—MTHFR—urinary bladder cancer	6.2e-05	0.000234	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—EGFR—urinary bladder cancer	6.14e-05	0.000232	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—SRC—urinary bladder cancer	6.1e-05	0.00023	CbGpPWpGaD
Zonisamide—CA4—Metabolism—GSTP1—urinary bladder cancer	6.09e-05	0.00023	CbGpPWpGaD
Zonisamide—CA3—Metabolism—EP300—urinary bladder cancer	6.06e-05	0.000229	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—TNF—urinary bladder cancer	6.04e-05	0.000228	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—EGFR—urinary bladder cancer	6.03e-05	0.000228	CbGpPWpGaD
Zonisamide—AOX1—Disease—NCOR1—urinary bladder cancer	6.02e-05	0.000228	CbGpPWpGaD
Zonisamide—SCN1A—Axon guidance—HRAS—urinary bladder cancer	6.01e-05	0.000227	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—SRC—urinary bladder cancer	6.01e-05	0.000227	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—KRAS—urinary bladder cancer	5.99e-05	0.000226	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—TYMP—urinary bladder cancer	5.99e-05	0.000226	CbGpPWpGaD
Zonisamide—CA14—Metabolism—PPARG—urinary bladder cancer	5.97e-05	0.000226	CbGpPWpGaD
Zonisamide—CA9—Metabolism—NQO1—urinary bladder cancer	5.9e-05	0.000223	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—RHOA—urinary bladder cancer	5.86e-05	0.000221	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—TNF—urinary bladder cancer	5.85e-05	0.000221	CbGpPWpGaD
Zonisamide—CA2—Metabolism—GSTP1—urinary bladder cancer	5.84e-05	0.000221	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—PPARG—urinary bladder cancer	5.82e-05	0.00022	CbGpPWpGaD
Zonisamide—CA6—Metabolism—PPARG—urinary bladder cancer	5.82e-05	0.00022	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—KRAS—urinary bladder cancer	5.8e-05	0.000219	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—EGFR—urinary bladder cancer	5.77e-05	0.000218	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—TNF—urinary bladder cancer	5.74e-05	0.000217	CbGpPWpGaD
Zonisamide—CA14—Metabolism—CREBBP—urinary bladder cancer	5.73e-05	0.000217	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—KRAS—urinary bladder cancer	5.7e-05	0.000215	CbGpPWpGaD
Zonisamide—AOX1—Disease—ERCC2—urinary bladder cancer	5.66e-05	0.000214	CbGpPWpGaD
Zonisamide—CA4—Metabolism—TYMS—urinary bladder cancer	5.66e-05	0.000214	CbGpPWpGaD
Zonisamide—CA1—Metabolism—GSTP1—urinary bladder cancer	5.6e-05	0.000212	CbGpPWpGaD
Zonisamide—CA4—Metabolism—GSTM1—urinary bladder cancer	5.6e-05	0.000212	CbGpPWpGaD
Zonisamide—CA4—Metabolism—NCOR1—urinary bladder cancer	5.6e-05	0.000212	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—CREBBP—urinary bladder cancer	5.59e-05	0.000211	CbGpPWpGaD
Zonisamide—CA6—Metabolism—CREBBP—urinary bladder cancer	5.59e-05	0.000211	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—NQO1—urinary bladder cancer	5.56e-05	0.00021	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—EGFR—urinary bladder cancer	5.54e-05	0.000209	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—EGFR—urinary bladder cancer	5.54e-05	0.000209	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—TNF—urinary bladder cancer	5.49e-05	0.000208	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—GSTP1—urinary bladder cancer	5.49e-05	0.000207	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—KRAS—urinary bladder cancer	5.45e-05	0.000206	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—PPARG—urinary bladder cancer	5.43e-05	0.000205	CbGpPWpGaD
Zonisamide—CA7—Metabolism—PPARG—urinary bladder cancer	5.43e-05	0.000205	CbGpPWpGaD
Zonisamide—CA2—Metabolism—TYMS—urinary bladder cancer	5.43e-05	0.000205	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—ERBB2—urinary bladder cancer	5.42e-05	0.000205	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—NAT2—urinary bladder cancer	5.42e-05	0.000205	CbGpPWpGaD
Zonisamide—CA2—Metabolism—GSTM1—urinary bladder cancer	5.37e-05	0.000203	CbGpPWpGaD
Zonisamide—CA2—Metabolism—NCOR1—urinary bladder cancer	5.37e-05	0.000203	CbGpPWpGaD
Zonisamide—CA4—Metabolism—GPX1—urinary bladder cancer	5.36e-05	0.000203	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—EGFR—urinary bladder cancer	5.34e-05	0.000202	CbGpPWpGaD
Zonisamide—AOX1—Disease—MTHFR—urinary bladder cancer	5.32e-05	0.000201	CbGpPWpGaD
Zonisamide—AOX1—Disease—TERT—urinary bladder cancer	5.31e-05	0.000201	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—TNF—urinary bladder cancer	5.28e-05	0.000199	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—TNF—urinary bladder cancer	5.28e-05	0.000199	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—EGFR—urinary bladder cancer	5.27e-05	0.000199	CbGpPWpGaD
Zonisamide—CA4—Metabolism—ERCC2—urinary bladder cancer	5.26e-05	0.000199	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—KRAS—urinary bladder cancer	5.24e-05	0.000198	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—KRAS—urinary bladder cancer	5.24e-05	0.000198	CbGpPWpGaD
Zonisamide—CA7—Metabolism—CREBBP—urinary bladder cancer	5.22e-05	0.000197	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—CREBBP—urinary bladder cancer	5.22e-05	0.000197	CbGpPWpGaD
Zonisamide—CA1—Metabolism—TYMS—urinary bladder cancer	5.21e-05	0.000197	CbGpPWpGaD
Zonisamide—CA1—Metabolism—GSTM1—urinary bladder cancer	5.15e-05	0.000194	CbGpPWpGaD
Zonisamide—CA1—Metabolism—NCOR1—urinary bladder cancer	5.15e-05	0.000194	CbGpPWpGaD
Zonisamide—CA2—Metabolism—GPX1—urinary bladder cancer	5.14e-05	0.000194	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—TYMS—urinary bladder cancer	5.1e-05	0.000193	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—HRAS—urinary bladder cancer	5.09e-05	0.000192	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—TNF—urinary bladder cancer	5.09e-05	0.000192	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—KRAS—urinary bladder cancer	5.05e-05	0.000191	CbGpPWpGaD
Zonisamide—CA2—Metabolism—ERCC2—urinary bladder cancer	5.05e-05	0.000191	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—NCOR1—urinary bladder cancer	5.05e-05	0.000191	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—GSTM1—urinary bladder cancer	5.05e-05	0.000191	CbGpPWpGaD
Zonisamide—CA12—Metabolism—PPARG—urinary bladder cancer	5.03e-05	0.00019	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—KRAS—urinary bladder cancer	4.97e-05	0.000188	CbGpPWpGaD
Zonisamide—CA4—Metabolism—MTHFR—urinary bladder cancer	4.95e-05	0.000187	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GSTZ1—urinary bladder cancer	4.94e-05	0.000187	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—HRAS—urinary bladder cancer	4.93e-05	0.000186	CbGpPWpGaD
Zonisamide—CA1—Metabolism—GPX1—urinary bladder cancer	4.93e-05	0.000186	CbGpPWpGaD
Zonisamide—CA9—Metabolism—GSTP1—urinary bladder cancer	4.92e-05	0.000186	CbGpPWpGaD
Zonisamide—AOX1—Disease—FGFR3—urinary bladder cancer	4.87e-05	0.000184	CbGpPWpGaD
Zonisamide—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	4.85e-05	0.000183	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—HRAS—urinary bladder cancer	4.84e-05	0.000183	CbGpPWpGaD
Zonisamide—CA1—Metabolism—ERCC2—urinary bladder cancer	4.84e-05	0.000183	CbGpPWpGaD
Zonisamide—CA12—Metabolism—CREBBP—urinary bladder cancer	4.83e-05	0.000183	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—GPX1—urinary bladder cancer	4.83e-05	0.000183	CbGpPWpGaD
Zonisamide—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	4.78e-05	0.000181	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—ERCC2—urinary bladder cancer	4.74e-05	0.000179	CbGpPWpGaD
Zonisamide—CA2—Metabolism—MTHFR—urinary bladder cancer	4.74e-05	0.000179	CbGpPWpGaD
Zonisamide—CA14—Metabolism—PTGS2—urinary bladder cancer	4.69e-05	0.000177	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GSTO2—urinary bladder cancer	4.68e-05	0.000177	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—NAT1—urinary bladder cancer	4.68e-05	0.000177	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—RRM2—urinary bladder cancer	4.68e-05	0.000177	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—MMP9—urinary bladder cancer	4.65e-05	0.000176	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—GSTP1—urinary bladder cancer	4.64e-05	0.000175	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—HRAS—urinary bladder cancer	4.63e-05	0.000175	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	4.6e-05	0.000174	CbGpPWpGaD
Zonisamide—CA9—Metabolism—TYMS—urinary bladder cancer	4.58e-05	0.000173	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—PTGS2—urinary bladder cancer	4.58e-05	0.000173	CbGpPWpGaD
Zonisamide—CA6—Metabolism—PTGS2—urinary bladder cancer	4.58e-05	0.000173	CbGpPWpGaD
Zonisamide—CA1—Metabolism—MTHFR—urinary bladder cancer	4.55e-05	0.000172	CbGpPWpGaD
Zonisamide—CA9—Metabolism—NCOR1—urinary bladder cancer	4.52e-05	0.000171	CbGpPWpGaD
Zonisamide—CA9—Metabolism—GSTM1—urinary bladder cancer	4.52e-05	0.000171	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—MTHFR—urinary bladder cancer	4.46e-05	0.000169	CbGpPWpGaD
Zonisamide—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	4.45e-05	0.000168	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—HRAS—urinary bladder cancer	4.45e-05	0.000168	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—HRAS—urinary bladder cancer	4.45e-05	0.000168	CbGpPWpGaD
Zonisamide—MAOA—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	4.45e-05	0.000168	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—EP300—urinary bladder cancer	4.41e-05	0.000167	CbGpPWpGaD
Zonisamide—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	4.39e-05	0.000166	CbGpPWpGaD
Zonisamide—CA9—Metabolism—GPX1—urinary bladder cancer	4.33e-05	0.000164	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—HPGDS—urinary bladder cancer	4.33e-05	0.000164	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—ENO2—urinary bladder cancer	4.33e-05	0.000164	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—TYMS—urinary bladder cancer	4.31e-05	0.000163	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—HRAS—urinary bladder cancer	4.29e-05	0.000162	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—SRC—urinary bladder cancer	4.29e-05	0.000162	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—UGT2B7—urinary bladder cancer	4.28e-05	0.000162	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—PTGS2—urinary bladder cancer	4.27e-05	0.000161	CbGpPWpGaD
Zonisamide—CA7—Metabolism—PTGS2—urinary bladder cancer	4.27e-05	0.000161	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—NCOR1—urinary bladder cancer	4.26e-05	0.000161	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—GSTM1—urinary bladder cancer	4.26e-05	0.000161	CbGpPWpGaD
Zonisamide—CA9—Metabolism—ERCC2—urinary bladder cancer	4.25e-05	0.000161	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—HRAS—urinary bladder cancer	4.23e-05	0.00016	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—GSTT1—urinary bladder cancer	4.2e-05	0.000159	CbGpPWpGaD
Zonisamide—AOX1—Disease—CREBBP—urinary bladder cancer	4.15e-05	0.000157	CbGpPWpGaD
Zonisamide—CA14—Metabolism—PTEN—urinary bladder cancer	4.09e-05	0.000155	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—GPX1—urinary bladder cancer	4.08e-05	0.000154	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PPARG—urinary bladder cancer	4.01e-05	0.000152	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—ERCC2—urinary bladder cancer	4.01e-05	0.000151	CbGpPWpGaD
Zonisamide—CA9—Metabolism—MTHFR—urinary bladder cancer	4e-05	0.000151	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—PTEN—urinary bladder cancer	3.99e-05	0.000151	CbGpPWpGaD
Zonisamide—CA6—Metabolism—PTEN—urinary bladder cancer	3.99e-05	0.000151	CbGpPWpGaD
Zonisamide—CA12—Metabolism—PTGS2—urinary bladder cancer	3.96e-05	0.00015	CbGpPWpGaD
Zonisamide—CA14—Metabolism—EP300—urinary bladder cancer	3.9e-05	0.000148	CbGpPWpGaD
Zonisamide—CA4—Metabolism—CREBBP—urinary bladder cancer	3.85e-05	0.000146	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	3.85e-05	0.000146	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PPARG—urinary bladder cancer	3.85e-05	0.000145	CbGpPWpGaD
Zonisamide—CA6—Metabolism—EP300—urinary bladder cancer	3.81e-05	0.000144	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—EP300—urinary bladder cancer	3.81e-05	0.000144	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—MTHFR—urinary bladder cancer	3.77e-05	0.000142	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—EGFR—urinary bladder cancer	3.76e-05	0.000142	CbGpPWpGaD
Zonisamide—AOX1—Disease—RHOA—urinary bladder cancer	3.75e-05	0.000142	CbGpPWpGaD
Zonisamide—CA7—Metabolism—PTEN—urinary bladder cancer	3.73e-05	0.000141	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—PTEN—urinary bladder cancer	3.73e-05	0.000141	CbGpPWpGaD
Zonisamide—CA2—Metabolism—CREBBP—urinary bladder cancer	3.69e-05	0.00014	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PPARG—urinary bladder cancer	3.69e-05	0.000139	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	3.64e-05	0.000138	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PPARG—urinary bladder cancer	3.62e-05	0.000137	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—TNF—urinary bladder cancer	3.58e-05	0.000135	CbGpPWpGaD
Zonisamide—CA7—Metabolism—EP300—urinary bladder cancer	3.55e-05	0.000134	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—EP300—urinary bladder cancer	3.55e-05	0.000134	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—KRAS—urinary bladder cancer	3.55e-05	0.000134	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	3.55e-05	0.000134	CbGpPWpGaD
Zonisamide—CA1—Metabolism—CREBBP—urinary bladder cancer	3.54e-05	0.000134	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—NQO1—urinary bladder cancer	3.49e-05	0.000132	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—CREBBP—urinary bladder cancer	3.47e-05	0.000131	CbGpPWpGaD
Zonisamide—AOX1—Disease—ERBB2—urinary bladder cancer	3.47e-05	0.000131	CbGpPWpGaD
Zonisamide—CA12—Metabolism—PTEN—urinary bladder cancer	3.45e-05	0.00013	CbGpPWpGaD
Zonisamide—MAOA—Neuronal System—HRAS—urinary bladder cancer	3.41e-05	0.000129	CbGpPWpGaD
Zonisamide—AOX1—Disease—PTGS2—urinary bladder cancer	3.4e-05	0.000128	CbGpPWpGaD
Zonisamide—CA12—Metabolism—EP300—urinary bladder cancer	3.29e-05	0.000124	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PPARG—urinary bladder cancer	3.24e-05	0.000122	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PTGS2—urinary bladder cancer	3.16e-05	0.000119	CbGpPWpGaD
Zonisamide—CA9—Metabolism—CREBBP—urinary bladder cancer	3.11e-05	0.000118	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PPARG—urinary bladder cancer	3.06e-05	0.000115	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PTGS2—urinary bladder cancer	3.03e-05	0.000114	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—HRAS—urinary bladder cancer	3.02e-05	0.000114	CbGpPWpGaD
Zonisamide—AOX1—Disease—CDKN1A—urinary bladder cancer	2.97e-05	0.000112	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	2.97e-05	0.000112	CbGpPWpGaD
Zonisamide—AOX1—Disease—PTEN—urinary bladder cancer	2.96e-05	0.000112	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—CREBBP—urinary bladder cancer	2.94e-05	0.000111	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—GSTP1—urinary bladder cancer	2.91e-05	0.00011	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PTGS2—urinary bladder cancer	2.9e-05	0.00011	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PTGS2—urinary bladder cancer	2.84e-05	0.000107	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.84e-05	0.000107	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—TYMP—urinary bladder cancer	2.83e-05	0.000107	CbGpPWpGaD
Zonisamide—AOX1—Disease—EP300—urinary bladder cancer	2.82e-05	0.000107	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	2.81e-05	0.000106	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—NAT1—urinary bladder cancer	2.81e-05	0.000106	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PTEN—urinary bladder cancer	2.75e-05	0.000104	CbGpPWpGaD
Zonisamide—AOX1—Disease—SRC—urinary bladder cancer	2.75e-05	0.000104	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.72e-05	0.000103	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—TYMS—urinary bladder cancer	2.71e-05	0.000102	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—NCOR1—urinary bladder cancer	2.68e-05	0.000101	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—GSTM1—urinary bladder cancer	2.68e-05	0.000101	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PTEN—urinary bladder cancer	2.64e-05	9.97e-05	CbGpPWpGaD
Zonisamide—CA4—Metabolism—EP300—urinary bladder cancer	2.62e-05	9.92e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	2.57e-05	9.72e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—NAT2—urinary bladder cancer	2.56e-05	9.69e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—GPX1—urinary bladder cancer	2.56e-05	9.68e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PTGS2—urinary bladder cancer	2.55e-05	9.64e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PTEN—urinary bladder cancer	2.53e-05	9.56e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—EP300—urinary bladder cancer	2.52e-05	9.51e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—ERCC2—urinary bladder cancer	2.52e-05	9.5e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PTEN—urinary bladder cancer	2.48e-05	9.37e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—MYC—urinary bladder cancer	2.46e-05	9.3e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—EP300—urinary bladder cancer	2.41e-05	9.12e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—EGFR—urinary bladder cancer	2.41e-05	9.1e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PTGS2—urinary bladder cancer	2.4e-05	9.08e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—EP300—urinary bladder cancer	2.37e-05	8.94e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—MTHFR—urinary bladder cancer	2.36e-05	8.93e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	2.32e-05	8.76e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—KRAS—urinary bladder cancer	2.27e-05	8.59e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PTEN—urinary bladder cancer	2.22e-05	8.4e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—RRM2—urinary bladder cancer	2.21e-05	8.36e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	2.19e-05	8.27e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	2.13e-05	8.06e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—EP300—urinary bladder cancer	2.12e-05	8.01e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PTEN—urinary bladder cancer	2.1e-05	7.92e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	2.05e-05	7.74e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ENO2—urinary bladder cancer	2.05e-05	7.74e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.04e-05	7.7e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—EP300—urinary bladder cancer	2e-05	7.55e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	1.99e-05	7.51e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.96e-05	7.4e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—HRAS—urinary bladder cancer	1.93e-05	7.31e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PPARG—urinary bladder cancer	1.92e-05	7.24e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CREBBP—urinary bladder cancer	1.84e-05	6.96e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.7e-05	6.44e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—NQO1—urinary bladder cancer	1.65e-05	6.24e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.6e-05	6.06e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.54e-05	5.83e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PTGS2—urinary bladder cancer	1.51e-05	5.7e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.4e-05	5.28e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	1.38e-05	5.21e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.33e-05	5.04e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.33e-05	5.03e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PTEN—urinary bladder cancer	1.32e-05	4.97e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—TYMS—urinary bladder cancer	1.28e-05	4.84e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	1.27e-05	4.78e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	1.27e-05	4.78e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—EP300—urinary bladder cancer	1.25e-05	4.74e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.23e-05	4.66e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.23e-05	4.66e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GPX1—urinary bladder cancer	1.21e-05	4.58e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.2e-05	4.52e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	1.19e-05	4.5e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	1.12e-05	4.23e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—NQO1—urinary bladder cancer	9.93e-06	3.75e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PPARG—urinary bladder cancer	9.07e-06	3.43e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	8.72e-06	3.29e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	8.29e-06	3.13e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—TYMS—urinary bladder cancer	7.7e-06	2.91e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	7.61e-06	2.88e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	7.61e-06	2.88e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GPX1—urinary bladder cancer	7.29e-06	2.76e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	7.16e-06	2.71e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	7.14e-06	2.7e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	6.73e-06	2.54e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PTEN—urinary bladder cancer	6.23e-06	2.35e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—EP300—urinary bladder cancer	5.94e-06	2.24e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PPARG—urinary bladder cancer	5.46e-06	2.06e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	5.24e-06	1.98e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	4.29e-06	1.62e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PTEN—urinary bladder cancer	3.74e-06	1.41e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—EP300—urinary bladder cancer	3.57e-06	1.35e-05	CbGpPWpGaD
